HLA-B and myeloid sarcoma: Only in the HLA-B*0801+ sample subgroup (8 brain samples from 6 MS donors) was the frequency of CD8 T cells recognizing BZLF1 significantly higher than that of CD8 T cells recognizing EBNA3A (Fig. 6C).